Follow
Nathalie Johnson
Nathalie Johnson
Verified email at mcgill.ca
Title
Cited by
Cited by
Year
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
RD Morin, NA Johnson, TM Severson, AJ Mungall, J An, R Goya, JE Paul, ...
Nature genetics 42 (2), 181-185, 2010
19462010
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
RE Davis, VN Ngo, G Lenz, P Tolar, RM Young, PB Romesser, ...
Nature 463 (7277), 88-92, 2010
18692010
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
RD Morin, M Mendez-Lago, AJ Mungall, R Goya, KL Mungall, RD Corbett, ...
Nature 476 (7360), 298-303, 2011
18552011
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
NA Johnson, GW Slack, KJ Savage, JM Connors, S Ben-Neriah, S Rogic, ...
Journal of clinical oncology 30 (28), 3452, 2012
10952012
Phase II study of the efficacy and safety of pembrolizumab for relapsed/refractory classic Hodgkin lymphoma
R Chen, PL Zinzani, MA Fanale, P Armand, NA Johnson, P Brice, ...
Journal of Clinical Oncology 35 (19), 2125, 2017
9902017
MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy
KJ Savage, NA Johnson, S Ben-Neriah, JM Connors, LH Sehn, P Farinha, ...
Blood, The Journal of the American Society of Hematology 114 (17), 3533-3537, 2009
7932009
Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival
NA Johnson, KJ Savage, O Ludkovski, S Ben-Neriah, R Woods, C Steidl, ...
Blood, The Journal of the American Society of Hematology 114 (11), 2273-2279, 2009
7222009
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
C Steidl, SP Shah, BW Woolcock, L Rui, M Kawahara, P Farinha, ...
Nature 471 (7338), 377-381, 2011
6882011
Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing
RD Morin, K Mungall, E Pleasance, AJ Mungall, R Goya, RD Huff, ...
Blood, The Journal of the American Society of Hematology 122 (7), 1256-1265, 2013
4542013
EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis
I Velichutina, R Shaknovich, H Geng, NA Johnson, RD Gascoyne, ...
Blood, The Journal of the American Society of Hematology 116 (24), 5247-5255, 2010
3722010
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087
R Chen, PL Zinzani, HJ Lee, P Armand, NA Johnson, P Brice, J Radford, ...
Blood, The Journal of the American Society of Hematology 134 (14), 1144-1153, 2019
2962019
Systemic cancer therapy: achievements and challenges that lie ahead
MO Palumbo, P Kavan, W Miller, L Panasci, S Assouline, N Johnson, ...
Frontiers in pharmacology 4, 44276, 2013
2822013
Histological transformation and progression in follicular lymphoma: a clonal evolution study
R Kridel, FC Chan, A Mottok, M Boyle, P Farinha, K Tan, B Meissner, ...
PLoS medicine 13 (12), e1002197, 2016
2272016
Genetic landscapes of relapsed and refractory diffuse large B-cell lymphomas
RD Morin, S Assouline, M Alcaide, A Mohajeri, RL Johnston, L Chong, ...
Clinical cancer research 22 (9), 2290-2300, 2016
2272016
Prognostic factors in follicular lymphoma
T Relander, NA Johnson, P Farinha, JM Connors, LH Sehn, ...
J Clin Oncol 28 (17), 2902-2913, 2010
2162010
BCL2 predicts survival in germinal center B-cell–like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab
J Iqbal, PN Meyer, LM Smith, NA Johnson, JM Vose, TC Greiner, ...
Clinical Cancer Research 17 (24), 7785-7795, 2011
2102011
Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated with Worse Prognosis
KJJ Cheung, NA Johnson, JG Affleck, T Severson, C Steidl, S Ben-Neriah, ...
Cancer research 70 (22), 9166-9174, 2010
2082010
Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL
KJ Savage, GW Slack, A Mottok, LH Sehn, D Villa, R Kansara, R Kridel, ...
Blood, The Journal of the American Society of Hematology 127 (18), 2182-2188, 2016
1942016
Alemtuzumab for immune-related myocarditis due to PD-1 therapy
K Esfahani, N Buhlaiga, P Thébault, R Lapointe, NA Johnson, ...
New England Journal of Medicine 380 (24), 2375-2376, 2019
1862019
Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival
NA Johnson, M Boyle, A Bashashati, S Leach, A Brooks-Wilson, LH Sehn, ...
Blood, The Journal of the American Society of Hematology 113 (16), 3773-3780, 2009
1862009
The system can't perform the operation now. Try again later.
Articles 1–20